News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Business
American CryoStem Announces the Addition of Agustin Legido, MD, PhD, MBA to Its Advisory Board
December 22, 2022
·
4 min read
Policy
Therma Bright Provides 2022 Year End Update
December 21, 2022
·
8 min read
CVR Medical Corp. Announces Amended Restructuring Agreement with CVR Global, Inc.
December 20, 2022
·
6 min read
Breakthrough Results: Defence’s Novel AccuTOX(TM) Intranasal Reduced 50% of Cancer Nodules on Animals with Lung Tumors
December 20, 2022
·
5 min read
Drug Development
Skye Bioscience Receives FDA Authorization of Investigational New Drug Application for SBI-100 OE
December 20, 2022
·
4 min read
Scryb Announces New Contract Win for Cybeats with Fortune 500 Industrial Technology Company
December 19, 2022
·
4 min read
Drug Development
InFlectis BioScience Doses First Patient with IFB-088 in a Phase 2 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis
December 19, 2022
·
1 min read
Britannia Life Sciences Inc. Announces Results of Annual Meeting of Shareholders
December 16, 2022
·
3 min read
Drug Development
Skye Bioscience Doses First Cohort of Participants in Phase 1 Clinical Trial of SBI-100 Ophthalmic Emulsion
December 16, 2022
·
5 min read
BioHarvest Sciences Inc. Projects 2023 Revenue to Grow 3.0X-3.5X to a Range of USD $17M-$20M
December 15, 2022
·
5 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us